共 16 条
[1]
Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types. Kavanagh K,Pollock KG,Potts A,et al. British Journal of Cancer . 2014
[5]
The impact of HPV vaccination delays in China: Lessons from HBV control programs[J] . Danny V. Colombara,Shao-Ming Wang.  Vaccine . 2013
[6]
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis[J] . Talía Malagón,Mélanie Drolet,Marie-Claude Boily,Eduardo L Franco,Mark Jit,Jacques Brisson,Marc Brisson.  The Lancet Infectious Diseases . 2012 (10)
[7]
Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far[J] . Theodoros Agorastos,Konstantinos Chatzigeorgiou,Julia M.L. Brotherton,Suzanne M. Garland.  Vaccine . 2009 (52)
[8]
Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China[J] . Jing Li,Lian-Kun Li,Jun-Fei Ma,Li-Hui Wei,Mayinuer Niyazi,Chang-Qing Li,Ai-Di Xu,Jian-Bin Wang,Hao Liang,Jerome Belinson,You-Lin Qiao.  Vaccine . 2008 (8)